203 related articles for article (PubMed ID: 30948360)
1. Pharmacological management of abnormal tone and movement in cerebral palsy.
Lumsden DE; Crowe B; Basu A; Amin S; Devlin A; DeAlwis Y; Kumar R; Lodh R; Lundy CT; Mordekar SR; Smith M; Cadwgan J
Arch Dis Child; 2019 Aug; 104(8):775-780. PubMed ID: 30948360
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic interventions for reducing spasticity in cerebral palsy.
Patel DR; Soyode O
Indian J Pediatr; 2005 Oct; 72(10):869-72. PubMed ID: 16272661
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis.
Bohn E; Goren K; Switzer L; Falck-Ytter Y; Fehlings D
Dev Med Child Neurol; 2021 Sep; 63(9):1038-1050. PubMed ID: 33772789
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review.
Fehlings D; Brown L; Harvey A; Himmelmann K; Lin JP; Macintosh A; Mink JW; Monbaliu E; Rice J; Silver J; Switzer L; Walters I
Dev Med Child Neurol; 2018 Apr; 60(4):356-366. PubMed ID: 29405267
[TBL] [Abstract][Full Text] [Related]
5. Oral medication prescription practices of tertiary-based specialists for dystonia in children with cerebral palsy.
Harvey A; Reddihough D; Scheinberg A; Williams K
J Paediatr Child Health; 2018 Apr; 54(4):401-404. PubMed ID: 29105865
[TBL] [Abstract][Full Text] [Related]
6. Surgical Tone Reduction in Cerebral Palsy.
Thomas SP; Addison AP; Curry DJ
Phys Med Rehabil Clin N Am; 2020 Feb; 31(1):91-105. PubMed ID: 31760996
[TBL] [Abstract][Full Text] [Related]
7. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
; Delgado MR; Hirtz D; Aisen M; Ashwal S; Fehlings DL; McLaughlin J; Morrison LA; Shrader MW; Tilton A; Vargus-Adams J
Neurology; 2010 Jan; 74(4):336-43. PubMed ID: 20101040
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic management of spasticity in cerebral palsy.
Mooney JF; Koman LA; Smith BP
J Pediatr Orthop; 2003; 23(5):679-86. PubMed ID: 12960637
[No Abstract] [Full Text] [Related]
9. New approaches to managing spasticity in children with cerebral palsy.
Im D; McDonald CM
West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
[No Abstract] [Full Text] [Related]
10. Medication use in childhood dystonia.
Lumsden DE; Kaminska M; Tomlin S; Lin JP
Eur J Paediatr Neurol; 2016 Jul; 20(4):625-9. PubMed ID: 26924167
[TBL] [Abstract][Full Text] [Related]
11. [Spasticity in children cerebral palsy: diagnosis and treatment strategies].
Kurenkov AL; Batysheva TT; Vinogradov AV; Ziuziaeva EK
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7 Pt 2):24-8. PubMed ID: 23330188
[TBL] [Abstract][Full Text] [Related]
12. Spasticity: revisiting the role and the individual value of several pharmacological treatments.
Lapeyre E; Kuks JB; Meijler WJ
NeuroRehabilitation; 2010; 27(2):193-200. PubMed ID: 20871149
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal baclofen in dyskinetic cerebral palsy: effects on function and activity.
Eek MN; Olsson K; Lindh K; Askljung B; Påhlman M; Corneliusson O; Himmelmann K
Dev Med Child Neurol; 2018 Jan; 60(1):94-99. PubMed ID: 29148568
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy.
Navarrete-Opazo AA; Gonzalez W; Nahuelhual P
Arch Phys Med Rehabil; 2016 Apr; 97(4):604-618. PubMed ID: 26321489
[TBL] [Abstract][Full Text] [Related]
15. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy.
Kraus T; Gegenleitner K; Svehlik M; Novak M; Steinwender G; Singer G
Eur J Paediatr Neurol; 2017 May; 21(3):565-569. PubMed ID: 28237420
[TBL] [Abstract][Full Text] [Related]
16. Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review.
Pin TW; McCartney L; Lewis J; Waugh MC
Dev Med Child Neurol; 2011 Oct; 53(10):885-95. PubMed ID: 21635230
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic interventions for tone abnormalities in cerebral palsy.
Tilton AH
NeuroRx; 2006 Apr; 3(2):217-24. PubMed ID: 16554259
[TBL] [Abstract][Full Text] [Related]
18. [Management of spasticity in children with cerebral palsy].
Matthews DJ; Balaban B
Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346
[TBL] [Abstract][Full Text] [Related]
19. The management of cerebral palsy: subjectivity and a conundrum.
Bodensteiner JB
J Child Neurol; 1996 Mar; 11(2):75-76. PubMed ID: 8881980
[No Abstract] [Full Text] [Related]
20. Is baclofen the least worst option for spasticity management in children?
Brandenburg JE
J Pediatr Rehabil Med; 2023; 16(1):11-17. PubMed ID: 36938744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
